Search results for "Human fascioliasis"

showing 5 items of 15 documents

Human fascioliasis emergence risks in developed countries: From individual patients and small epidemics to climate and global change impacts

2020

Microbiology (medical)FascioliasisGeographySpainHuman fascioliasisDeveloped CountriesIncidenceDevelopment economicsHumansGlobal changeEpidemicsDeveloped countryEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Very High Fascioliasis Intensities in Schoolchildren from Nile Delta Governorates, Egypt: The Old World Highest Burdens Found in Lowlands

2021

Quantitative coprological analyses of children were performed in Alexandria and Behera governorates, Egypt, to ascertain whether individual intensities in the Nile Delta lowlands reach high levels as those known in hyperendemic highland areas of Latin America. Analyses focused on subjects presenting intensities higher than 400 eggs per gram of faeces (epg), the high burden cut-off according to WHO classification. A total of 96 children were found to shed between 408 and 2304 epg, with arithmetic and geometric means of 699.5 and 629.07 epg, respectively. Intensities found are the highest hitherto recorded in Egypt, and also in the whole Old World. A total of 38 (39.6%) were males and 58 (60.…

Microbiology (medical)Veterinary medicineOld WorldDiagnostic methodshigh intensitieshuman fascioliasisArticlechildrencoprologyparasitic diseasesQuantitative assessmentgeographical distributionImmunology and AllergyNile deltaMolecular BiologyFecesEggs per gramAlexandria and Behera governoratesNile DeltaGeneral Immunology and Microbiologygender and ageRPathogenicityInfectious DiseasesGeographyMedicineEgyptWho classificationPathogens
researchProduct

Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.

2004

1. A study performed > 10 years ago and case reports published recently suggest that triclabendazole is effective for the treatment of patients with fascioliasis. 2. To confirm the efficacy of a human formulation of triclabendazole, we enrolled 165 patients into the present study and divided the subjects into two groups: (i) those who had fascioliasis, as evidenced by the presence of ova in their stools; and (ii) patients with clinical and laboratory data suggesting fascioliasis. 3. Patients were randomly allocated to receive 10 mg/kg, p.o., triclabendazole for 1, 2 or 3 days (single-, double- and triple-dose groups, respectively). Medical history and physical and laboratory examinations we…

Toxic hepatitisAdultMalemedicine.medical_specialtyCure rateFascioliasisAdolescentPhysiologyChemistry PharmaceuticalGastroenterologylaw.inventionFecesRandomized controlled triallawOral administrationPhysiology (medical)Internal medicineMedicineHumansMedical historyIn patientChildTriclabendazoleAgedPharmacologyAnthelminticsDose-Response Relationship Drugbusiness.industryMiddle AgedSurgeryTriclabendazoleTreatment OutcomeHuman fascioliasisImmunoglobulin GBenzimidazolesFemalemedicine.symptombusinessmedicine.drugClinical and experimental pharmacologyphysiology
researchProduct

Donkey Fascioliasis Within a One Health Control Action: Transmission Capacity, Field Epidemiology, and Reservoir Role in a Human Hyperendemic Area.

2020

A One Health initiative has been implemented for fascioliasis control in a human hyperendemic area for the first time. The area selected for this multidisciplinary approach is the Northern Bolivian Altiplano, where the highest prevalences and intensities in humans have been reported. Within the strategic intervention axis of control activities concerning animal reservoirs, complete experimental studies, and field surveys have been performed to assess the fascioliasis transmission capacity and epidemiological role of the donkey for the first time. Laboratory studies with altiplanic donkey-infecting Fasciola hepatica and altiplanic Galba truncatula snail vector isolates demonstrate that the d…

Veterinary medicineBolivia040301 veterinary sciencesSnaildonkeylaw.inventionhuman fascioliasis hyperendemic0403 veterinary science03 medical and health sciencesHepaticalawbiology.animalFasciola hepaticaOne Health030304 developmental biologyGalba truncatulaOriginal Research0303 health scienceslcsh:Veterinary medicineGeneral Veterinarybiology04 agricultural and veterinary sciencesLiver flukeFasciola hepaticabiology.organism_classificationreservoir roleTransmission (mechanics)Vector (epidemiology)lcsh:SF600-1100field epidemiologyVeterinary ScienceDonkeyGalba truncatula experimental transmissionFrontiers in veterinary science
researchProduct

Analysis of climatic data and forecast indices for human fascioliasis at very high altitude

1999

Human infection with Fasciola hepatica has recently been recognized as an important health problem worldwide, and particularly at very high altitudes in South America. The highest prevalences and intensities of human fascioliasis known are those of the northern Bolivian Altiplano, where infected Lymnaea truncatula occur at altitudes of 3800-4100 m. In the present study, the climatic data for this area of the Altiplano, which differ markedly from those of endemic areas in the lowlands, were analysed. There is no marked seasonality in temperature but there are large variations in temperature within a daily, 24-h period. Rainfall is seasonal, with a long dry season, coinciding with the lowest …

Wet seasonEcology030231 tropical medicineEffects of high altitude on humansSeasonalitymedicine.diseaseClimatic data03 medical and health sciences0302 clinical medicineInfectious DiseasesAltitudeHuman fascioliasis030225 pediatricsEvapotranspirationDry seasonmedicineEnvironmental scienceParasitologyPhysical geographyAnnals of Tropical Medicine & Parasitology
researchProduct